MTSS1 Antibody

1. MTSS1 is stabilized by the protein phosphatase activity of the tumor suppressor PTEN. Our data show that PTEN loss in PDAC cells results in both increased metastatic potential and decreased MTSS1 expression. Furthermore, we show that ectopic MTSS1 expression rescues this effect. PMID: 29175021
2. These data suggested that miR-411 played as oncogene in the osteosarcoma partly by inhibiting the MTSS1 expression. . PMID: 29453719
3. Missing in metastasis B, regulated by DNMT1, functions as a putative cancer suppressor in human lung giant-cell carcinoma. PMID: 28159994
4. Data identify MTSS1 as a new Akt2-regulated gene, and point to suppression of MTSS1 as a key step in the metastasis-promoting effects of Akt2 in CRC cells. PMID: 28068324
5. Data suggest that overexpression of MAEL, caused by gene amplification and/or decreased miR-186, has a critical oncogenic role in UCB pathogenesis by downregulation of MTSS1. PMID: 27181205
6. Overexpression of MTSS1 in PDAC cell lines leads to a loss of migratory potential in vitro and an increase in overall survival in vivo. Data provide insight into an important role for MTSS1 in suppressing tumor cell invasion and migration driven by the tumor microenvironment. PMID: 28146435
7. Overexpression of MTSS1 reduced BUCC cell proliferation, cell-cycle progression and colony formation, but had no influence on BUCC cell apoptosis. PMID: 28739745
8. in contrast to MIM, which is a prototype of I-BAR proteins and does not contain an SH3 domain, IRTKS promoted serum-induced cell migration along with enhanced phosphorylation of mitogen activated kinases Erk1/2 and p38 PMID: 27693783
9. MTSS1 suppressed H1299 cell migration and invasion, and its expression level can be used as a new independent factor for determining the prognosis of non-small cell lung cancer. PMID: 27634022
10. MTSS1 is a new authentic target of miR-96 in prostate carcinoma. PMID: 27164937
11. Down-regulation of MTSS1 expression is associated with lymph node metastasis in Pancreatic Cancer. PMID: 26198729
12. Low expression of Mtss1 is associated with Chronic myeloid leukemia. PMID: 26621336
13. MTSS1 plays an essential inhibitory role in the development and progression of ovarian cancers PMID: 26316204
14. our findings suggest that MTSS1 might have a context-dependent function and could act as a tumor suppressor, which is pharmacologically targetable in AML patients. PMID: 25996952
15. EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer. PMID: 25783158
16. These results implicate that the role of MTSS1 suppresses cell migration and invasion by inhibiting expression of CTTN and as a prognosis biomarker in Glioblastomas PMID: 25385572
17. Data shows that MTSS1 is highly expressed in non-small-cell lung carcinomas compared with non-neoplastic lung tissues and may serve as an independent prognostic factor. PMID: 25625275
18. The absence of MIM led to PTPdelta-mediated activation of SRC. PMID: 25287652
19. MTSS1 expression was analyzed in normal and cancerous tissue specimens from Chinese patients with Hilar cholangiocarcinoma. PMID: 23852458
20. MTSS1 is a metastasis driver in a subset of human melanomas. PMID: 24632752
21. In breast tumor samples, miR-182 induction is linked to downregulation of MIM, RhoA activation and poor prognosis. PMID: 23474751
22. Compared with normal tissue, miR-182 was up-reg'd and MTSS1 was down-reg'd in HCC tissues. Over-expression of miR-182 was correlated with intrahepatic metastasis. There was a negative correlation between miR-182 and MTSS1 expression in both HCC tissues. PMID: 22681717
23. Data show that the expression of the metastasis suppressor 1 (MTSS1) gene was regulated by miR-135a overexpression and knockdown. PMID: 23017832
24. Loww MTSS1 expression is associated with kidney cancer. PMID: 23350348
25. MiR-23a expression promotes colon carcinoma cell growth, invasion and metastasis through inhibition of the MTSS1 gene. PMID: 22455847
26. the dimeric configuration is essential for MIM-mediated membrane remodelling and serves as a proper target to develop antagonists specifically against an I-BAR-domain-containing protein. PMID: 22721729
27. MTSS1 was characterized as a novel tumor suppressor gene in hepatocellular carcinoma PMID: 21909138
28. Data show that Mtss1 drives enhanced junction formation specifically by elevating Rac-GTP. PMID: 22479308
29. at high cell densities, Mtss1 impacts negatively on EGF signaling and this suggests why it inhibits metastasis. PMID: 21927027
30. Anthrax edema toxin induced transendothelial cell tunnels are resealed by MIM via Arp2/3-driven actin polymerization. PMID: 22100162
31. MTSS1 is expressed at low levels or is absent from human bladder cancer cells. PMID: 21965727
32. MTSS1 serves as a potential prognostic indicator in human oesophageal squamous cell carcinoma and may be an important target for cancer therapy. PMID: 21696600
33. the current knowledge of MTSS1's role in cancer metastasis, carcinogenesis, and development is discussed. PMID: 21196400
34. Downregulation of metastasis suppressor 1 is associated with nodal metastasis and gastric cancer. PMID: 20712855
35. a potential metastasis suppressor gene in bladder cancer; data suggest that it may be involved in cytoskeletal organization PMID: 12082544
36. missing in metastasis protein and insulin receptor tyrosine kinase substrate p53 have a conserved novel actin bundling/filopodium-forming domain PMID: 14752106
37. Our data indicate that down-regulation of MIM and/or MIM-B expression can occur in bladder cancer cell lines but is not associated with increased invasive behaviour. PMID: 15488640
38. MIM-B is unlikely to be a metastasis suppressor but acts as a scaffold protein that interacts with Rac, actin and actin-associated proteins to modulate lamellipodia formation. PMID: 16280553
39. The expression of metastasis suppressor MIM is regulated by DNA methylation of a CpG island within its promoter region. PMID: 16921485
40. Elevated MIM-B expression may influence the development of hepatocellular carcinoma and may possibly be a powerful indicator for the disease at an early stage. PMID: 17442377
41. MTSS1 is a prognostic indicator of disease-free survival in breast cancer patients and demonstrates the ability to play a role in governing the metastatic nature of breast cancer cells. PMID: 19328678
42. MTSS1, also known as MIM, is a modular hedgehog inducible protein that contains a dimerization domain and a distinct activation/scaffolding domain that binds RPTPdelta and induces membrane projections. PMID: 15684034
43. MTSS1, also known as MIM, is a hedgehog inducible protein expressed in carcinomas that potentiates Gli transcription factor activity PMID: 15545630

Show More

Hide All

HGNC: 20443

OMIM: 608486

KEGG: hsa:9788

STRING: 9606.ENSP00000429064

UniGene: Hs.336994